Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

Population pharmacokinetics of risperidone and 9-hydroxyrisperidone in patients with acute episodes associated with bipolar I disorder

Publication: J Pharmacokinet Pharmacodyn

A population model was developed with the aim to simultaneously describe risperidone and 9-hydroxyrisperidone pharmacokinetics; to obtain estimates for pharmacokinetic parameters and associated...

Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract

Selective activation of estrogen receptor-beta transcriptional pathways by an herbal extract

Publication: Endocrinology
Division: PBPK

Novel estrogenic therapies are needed that ameliorate menopausal symptoms and have the bone-sparing effects of endogenous estrogens but do not promote breast or...

In Silico Prediction of Ionization

In Silico Prediction of Ionization

Authors: Fraczkiewicz R
Publication: Comprehensive Medicinal Chemistry II, Vol. 5
Software: ADMET Predictor®
Division: PBPK

The focus of this chapter is computational methods for the prediction of aqueous ionization of organic molecules.

Population Pharmacokinetics of (R)-Albuterol Following Inhaled Levalbuterol or Racemic Albuterol via a Hydrofluoroalkane Metered Dose Inhaler in Pediatric and Adult Asthma Patients

Population Pharmacokinetics of (R)-Albuterol Following Inhaled Levalbuterol or Racemic Albuterol via a Hydrofluoroalkane Metered Dose Inhaler in Pediatric and Adult Asthma Patients

Conference: AAPS

Levalbuterol (LEV), the (R)-enantiomer of racemic albuterol (RA), is approved for the treatment or prevention of bronchospasm in patients ≥4 years of age via metered dose inhaler (MDI). A population…